Interpretation of R2-CHOP in large cell lymphoma


During ICML 2019 in Lugano, Switzerland, the Lymphoma Hub were pleased to speak to Nathan Fowler, MD Anderson Cancer Center, Houston, US, and Chan Cheah, Sir Charles Gairdner Hospital, Nedlands, AU, about the latest trials in malignant lymphomas.

They discussed the results of trials investigating the use of CHOP chemotherapy and lenalidomide in newly diagnosed large cell lymphoma, and how two trials using these regimens had differing outcomes.

Prof Cheah spoke of the differences of these trials, such as the varying dosage of lenalidomide, and the positive and negative results of the two studies.

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF